Article Information
History
- January 9, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Aline Pfefferle1,*,
- Benedikt Jacobs2,3,†,
- Eivind Heggernes Ask2,3,
- Susanne Lorenz4,
- Trevor Clancy2,3,
- Jodie P. Goodridge2,3,
- Ebba Sohlberg1 and
- Karl-Johan Malmberg1,2,3,*
- 1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
- 2Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
- 3The KG Jebsen Center for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 4Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
- ↵*Corresponding authors. Email: aline.pfefferle{at}ki.se, kalle.malmberg{at}ki.se